BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18570062)

  • 1. Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms.
    Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    Aging Male; 2008 Jun; 11(2):95-9. PubMed ID: 18570062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
    Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with human chorionic gonadotropin for PADAM: a preliminary report.
    Tsujimura A; Matsumiya K; Takao T; Miyagawa Y; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
    Aging Male; 2005; 8(3-4):175-9. PubMed ID: 16390742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
    Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism.
    Jungwirth A; Plas E; Geurts P
    Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders.
    Okamura K; Nojiri Y; Osuga Y
    BJU Int; 2009 Jun; 103(12):1673-8. PubMed ID: 19154505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging Males' Symptoms scale in Japanese men attending a multiphasic health screening clinic.
    Ichioka K; Nishiyama H; Yoshimura K; Itoh N; Okubo K; Terai A
    Urology; 2006 Mar; 67(3):589-93. PubMed ID: 16504258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of major depressive disorder in self-referred patients in a late onset hypogonadism clinic.
    Sato Y; Tanda H; Kato S; Onishi S; Nakajima H; Nanbu A; Nitta T; Koroku M; Akagashi K; Hanzawa T
    Int J Impot Res; 2007; 19(4):407-10. PubMed ID: 17460698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
    Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
    Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].
    Taniguchi H; Kawa G; Kinoshita H; Matsuda T
    Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Kampo formula, saikokaryukotsuboreito, improves serum testosterone levels of castrated mice and its possible mechanism.
    Michihara S; Shin N; Watanabe S; Morimoto Y; Okubo T; Norimoto H
    Aging Male; 2013 Mar; 16(1):17-21. PubMed ID: 23339665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.
    Noguchi M; Kakuma T; Tomiyasu K; Yamada A; Itoh K; Konishi F; Kumamoto S; Shimizu K; Kondo R; Matsuoka K
    Asian J Androl; 2008 Sep; 10(5):777-85. PubMed ID: 18097505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
    Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.
    Tsujimura A; Matsumiya K; Miyagawa Y; Takao T; Fujita K; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
    Int J Impot Res; 2005; 17(3):259-63. PubMed ID: 15616608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.
    Kalinchenko S; Vishnevskiy EL; Koval AN; Mskhalaya GJ; Saad F
    Aging Male; 2008 Jun; 11(2):57-61. PubMed ID: 18570056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
    Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
    Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
    Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
    BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.